Reduced Intensity Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Sirolimus/Mycophenolate Mofetil/RGI-2001 Based GVHD Prevention: a Pilot Study
Latest Information Update: 30 Oct 2023
At a glance
- Drugs Alpha galactosylceramide (Primary) ; Cyclophosphamide; Fludarabine; Melphalan; Mycophenolate mofetil; Mycophenolate mofetil; Sirolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 25 Oct 2023 Planned End Date changed from 1 Dec 2023 to 1 Oct 2024.
- 25 Oct 2023 Status changed from recruiting to active, no longer recruiting.
- 30 Sep 2021 Planned End Date changed from 1 Feb 2023 to 1 Dec 2023.